Experience the Quality With Free CCP-C Exam Questions That Helps Candidates Pass

In ARDS, lung-protective ventilation prioritizes low tidal volumes (≈6 mL/kg PBW) and limits plateau pressure ≤30 cm H₂O. Persistent hypoxemia despite FiO₂ 0.60 and PEEP 12 suggests need for a higher PEEP strategy to recruit alveoli and improve V/Q matching. Incremental PEEP increases (e.g., by 2 cm H₂O) with close monitoring of plateau pressure, driving pressure (plateau − PEEP), and blood pressure are appropriate. Raising VT (A) risks volutrauma and increased plateau pressure. Decreasing RR (C) would likely worsen oxygenation and hypercapnia. Jumping to 100% FiO₂ (D) can be temporarily used for severe desaturation, but prolonged high FiO₂ increases oxygen toxicity risk and does not address low end-expiratory alveolar recruitment. Also consider prone positioning at the receiving facility, ensure adequate sedation, and evaluate for neuromuscular blockade if indicated by protocol and consulting team guidance.

Refractory pediatric anaphylaxis requires continuous epinephrine via IV/IO to address both vasoplegia (α1) and bronchospasm (β2). Phenylephrine (A) lacks β-activity and may worsen bronchospasm. Diltiazem (C) risks hypotension and does not address the pathophysiology. Diuresis (D) is not indicated; “edema” reflects capillary leak, not fluid overload amenable to loop diuretics. Titrate epinephrine carefully with continuous monitoring, provide H1/H2 blockers and corticosteroids as adjuncts, and continue aggressive but judicious fluid resuscitation while watching for pulmonary compromise. Prepare for airway deterioration: have appropriately sized airway equipment ready, and maintain ongoing reassessment of perfusion endpoints and mental status during transport.

Low-dose ketamine provides potent, opioid-sparing analgesia via NMDA antagonism with minimal respiratory depression and generally stable hemodynamics—ideal in opioid tolerance. It improves ventilator synchrony, mitigates central sensitization, and reduces total opioid requirement. Benzodiazepines (A) offer amnesia, not analgesia, and increase delirium and hypotension risk. NSAID monotherapy (C) is inadequate and may be contraindicated (bleeding/renal risk). Propofol (D) provides sedation without analgesia and can worsen hypotension. Start a low ketamine infusion after a small bolus if needed; monitor for sialorrhea or psychoperceptual effects (rare at analgesic dosing) and treat with anticholinergic if necessary. Continue multimodal analgesia (acetaminophen, regional techniques at destination) and maintain an explicit pain/sedation target (e.g., CPOT/RASS), reassessing frequently.

This is classic dynamic hyperinflation (auto-PEEP) causing reduced venous return and hypotension. A transient circuit disconnect lets trapped gas escape, immediately lowering intrathoracic pressure and restoring preload. Then adjust the ventilator: lower rate, reduce tidal volume if needed, and increase inspiratory flow to shorten inspiratory time, thereby lengthening expiratory time. Continue aggressive bronchodilation and consider ketamine for bronchodilation/sedation. Increasing PEEP (C) risks raising total PEEP in severe obstruction. Raising RR (A) shortens expiratory time and worsens trapping. Bicarbonate (D) treats severe acidemia but doesn’t resolve the mechanical cause. Reassess with an end-expiratory hold to quantify auto-PEEP, track EtCO₂ waveform (“shark-fin” improvement), and monitor hemodynamics closely; repeat the brief disconnect only if life-threatening and with high FiO₂ preoxygenation.

In catecholamine-driven AF during septic shock, AV-nodal blockers (diltiazem, esmolol) can precipitate hypotension by reducing inotropy and vasomotor tone. Amiodarone provides rate and potential rhythm control with comparatively less acute negative inotropy, allowing continuation of vasopressors while stabilizing the rhythm. Adenosine treats AVNRT/AVRT, not atrial fibrillation. Esmolol may be useful in carefully selected, monitored ICU settings after hemodynamics are secured; during transport with marginal MAP, it is risky. Start amiodarone with a standard bolus (e.g., 150 mg over 10 minutes) followed by infusion, watch QTc and interactions, and correct electrolytes (Mg²⁺, K⁺). If the patient becomes unstable (hypotension, ischemia), synchronized cardioversion is indicated. This approach aligns with CCP-C objectives: protect perfusion first, avoid iatrogenic hypotension, and choose agents compatible with shock physiology while continuously reassessing BP, mental status, urine output, lactate, and EtCO₂.